Beyond Cystic Fibrosis: Recognising Shwachman‐Diamond Syndrome in the Respiratory Clinic Authors: Freda Yang, Ladina Weitnauer, Imogen Felton, Nicholas J Simmonds Published: 2025 ABSTRACT ABSTRACTCystic fibrosis (CF) and Shwachman‐Diamond Syndrome (SDS) share overlapping features, including recurrent respiratory infections and pancreatic insufficiency, which can complicate diagnosis. We report a case of a six‐year‐old girl who presented with productive cough, steatorrhea and recurrent infections. Initial evaluation showed abnormal liver enzymes, elevated immunoreactive trypsin, neutrophil dysfunction and skeletal anomalies. Sweat test was equivocal and CFTR genetic panel was negative. Further genomic analysis identified compound heterozygous mutations in the SBDS gene: c.258+2T>C (known pathogenic variant) and c.284T>A (novel variant), confirming SDS. Over a 42‐year follow‐up, she experienced intermittent neutropenia, recurrent respiratory infections and pregnancy‐related complications. This case emphasises the importance of considering SDS in CF‐like presentations with atypical features and equivocal CF testing. Milder SDS phenotypes can survive into adulthood. Further work is needed to refine genotype–phenotype correlations and guide long‐term management.Keywords: CFTR, cystic fibrosis, SDBS, Shwachman‐Diamond Syndrome Introduction Cystic Fibrosis (CF) is a well‐known autosomal recessive disorder primarily affecting the respiratory and gastrointestinal systems, characterised by recurrent respiratory infections, bronchiectasis and exocrine pancreatic insufficiency [1]. Shwachman‐Diamond Syndrome (SDS) is an extremely rare condition (1 in 75,000–100,000 live births) that can mimic CF during childhood due to overlapping features such as recurrent infections and pancreatic dysfunction [2]. Given this overlap, clinicians should consider SDS in CF‐like presentations, particularly when atypical features, such as cytopenia or skeletal anomalies, are present. We describe a patient diagnosed with SDS in childhood and followed for 42 years, highlighting key differences in evaluation, management and prognosis. Case Report A six‐year‐old girl presented with a one‐week history of productive cough and chronic steatorrhea. She was born at 41 weeks and was ‘smaller than her peers’ throughout childhood. Past history included sinusitis, eczema and recurrent respiratory, urinary tract and skin infections. Family history featured respiratory illnesses (pneumonia and tuberculosis). Her 29‐year‐old mother had adult‐onset asthma, bronchiectasis, recurrent nasal polyps, and mixed hearing loss. Examination identified bony anomalies. Laboratory investigations showed elevated liver transaminases (GGT, ALT, AST) and serum immunoreactive trypsin, which suggested exocrine pancreatic insufficiency. Sputum culture grew Haemophilus influenzae . Immunological testing showed impaired neutrophil locomotion and chemotaxis, with preserved monocyte function. Sweat testing showed borderline sweat sodium concentrations (43 and 48 mEq/L), the diagnostic gold standard for CF at that time. Ciliary function was normal. A presumptive diagnosis of SDS was made based on clinical presentation and equivocal sweat results. CF genetic testing, approximately 12 years later, found no identifiable cystic fibrosis transmembrane conductance regulator (CFTR) variants. Comprehensive SDS genetic analysis (bi‐directional Sanger sequencing in all five exons of the Schwachman‐Bodian‐Diamond syndrome [SBDS] gene) identified a pathogenic variant (c.258+2T>C) and in trans novel missense variant (c.284T>A, p.Val95Glu). This codon has been previously implicated in SDS, with a different amino acid substitution at the same position (c.284T>G; p.Val95Gly) reported by Scalais et al. [3], which supports the pathogenicity of our variant and provides molecular confirmation of SDS 29 years after the initial clinical diagnosis. In adulthood, she experienced a miscarriage at 25 weeks and pre‐eclampsia in two subsequent pregnancies. Aged 48, she has intermittent neutropenia. Liver transaminases are within the normal range, but she remains pancreatic insufficient. Despite frequent lower respiratory infections, spirometry is normal. Chest CT shows bronchial wall thickening and mucous plugging without bronchiectasis. Discussion SDS and CF overlap in early life, most notably with pancreatic insufficiency and recurrent infections, but skeletal anomalies, cytopenia and bone marrow dysfunction are characteristics of SDS [2]. SDS should be considered when CF investigations are negative or equivocal, particularly if extensive CFTR analysis is inconclusive. CF results from CFTR protein dysfunction leading to dehydrated secretions, ductal obstruction and infection [1]. SDS is due to biallelic mutations in SBDS, a gene involved in ribosome assembly. Infection risk in SDS is driven in part by neutrophil dysfunction, particularly impaired chemotaxis [4]. Interestingly, both SBDS and CFTR are located on chromosome 7. Pancreatic disease occurs in both conditions but often diverges over time. In SDS, > 90% have early exocrine dysfunction from fatty infiltration and acinar atrophy, but function may improve with age. In CF, this results from obstruction of pancreatic ducts, which leads to progressive fibrosis and pancreatic insufficiency (sometimes acute recurrent pancreatitis is the main feature) [1]. Liver involvement also differs. In SDS, elevated transaminases are common in childhood and often resolve, though cholestasis and cirrhosis can occur. In CF, liver issues include fatty infiltration or biliary cirrhosis [1]. Skeletal and haematological findings distinguish SDS from CF. Metaphyseal dysplasia, delayed epiphyseal ossification, and low‐turnover osteoporosis may occur in SDS [2]. Bone‐marrow failure manifests as intermittent or persistent cytopenia, with a significant risk (10%–36%) of transformation into myelodysplastic syndrome and acute myeloid leukaemia [5]. This mostly accounts for the reduced life expectancy (age 38–41). Recurrent miscarriages occur more frequently in SDS, though live birth rates remain similar to the general population [6]. Additional SDS features are summarised in Table 1. TABLE 1Summary of Shwachman‐Diamond Syndrome (SDS) versus Cystic Fibrosis (CF).Shwachman‐Diamond Syndrome (SDS)Cystic Fibrosis (CF)EpidemiologyIncidence1 in 75,000–100,000 live births, higher incidence in males (ratio 1.7:1)1 in 2500 live births (Europe and North America)Life expectancySurvival into the third and fourth decades of life reportedSurvival varies across the world depending on access to treatments and MDT (median predicted survival in the UK and US was > 60 years in 2023)PresentationRespiratory disease & Infections Recurrent respiratory infections, often milder than CF Lung disease may progress slowly. Bronchiectasis uncommon early Progressive lung disease (can be severe) Chronic cough, recurrent pneumonia, bronchiectasis, ABPA, chronic infections, for example, with Pseudomonas aeruginosa , Burkholderia cepacia complex, Mycobacterium abscesses Pancreatic Exocrine pancreatic dysfunction in > 90%, typically within first year of diagnosis. In some, function improves spontaneously in childhood Pancreas shows fatty infiltration and acinar cell atrophy Exocrine pancreatic insufficiency is common (90% patients) due to ductal obstruction by thick mucus Pancreatic fibrosis and atrophy are progression. Enzyme replacement is lifelong GastrointestinalSteatorrhea, fat‐soluble vitamin deficiencies (A, D, E, K), failure to thriveMeconium ileus in neonates; distal intestinal obstruction syndrome (DIOS); malabsorption, steatorrhea. Fat‐soluble vitamin deficiencies (A, D, E, K). Failure to thriveLiverElevated liver transaminases are very common in infants and children but resolve with age. Hepatomegaly common. Chronic liver disease rareHepatic steatosis common. Biliary cirrhosis and portal hypertension (CF liver disease). Risk of gallstones. Drug‐induced liver injury (e.g., from antibiotics, CFTR modulators)Haematological Bone marrow failure: neutropenia (most common), anaemia, thrombocytopenia are intermittent or persistent Increased risk of myelodysplastic syndrome and leukaemia, most commonly acute myeloid leukaemia No haematological abnormalities Secondary anaemia may occur with chronic disease, infections, iron‐deficiency Skeletal Metaphyseal dysplasia Delayed epiphyseal ossification Thoracic dystrophy Low‐turnover Osteoporosis Hypertrophic pulmonary osteoarthropathy Osteopenia and osteoporosis – multifactorial, for example, due to chronic corticosteroid use and malabsorption of vitamin D and K Neurocognitive and Psychological Neurocognitive deficits possible. MRI studies show decreased brain volume, especially posterior fossa Developmental delays and learning difficulties may occur No direct neurocognitive abnormalities Psychological problems related to chronic illness (anxiety, depression, treatment burden) FertilityIncreased rate of miscarriages. Fertility in males and females generally preserved Congenital bilateral absence of vas deferens (CBAVD) in males; obstructive azoospermia Females may have subfertility (which generally improves if responsive to CFTR modulators) Others Endocrine dysfunction, such as hypothyroidism, glucose dysregulation or diabetes Congenital defects Increased risk of oral and dental disease Visual abnormalities (rod‐cone dystrophy) Sensorineural hearing loss CF diabetes Nasal polyps, sinusitis DiagnosticsPathophysiology Exact pathogenesis is unclear Affected SDBS protein is involved in ribosome biogenesis and mitotic spindle stabilisation Absence or decreased function of the CFTR protein which is an ion channel transporting anions (chloride, bicarbonate) across epithelial apical cell membranesSweat chloride levels Below 60 mmol/L Elevated (≥ 60 mmol/L) Borderline (30–59 mmol/L), but may be diagnostic if further functional tests (e.g., NPD) are abnormal Genetics Usually autosomal recessive Common: variants in the SBDS gene (causes SDS1) Rare: variants in the EFL1 gene (causes SDS2) and DNAJC21 gene (responsible for bone marrow failure syndrome) Rarely autosomal dominant: SRP54 gene (is linked with Shwachman‐Diamond syndrome like (SDSL) and neutropenia) Autosomal recessive > 2000 CFTR variants identified Most common in European and North American populations: common variants include F508del, G551D, G542X ManagementMonitoring Full blood counts every 3–6 months Bone marrow monitoring as indicated Monitor liver enzymes and fat‐soluble vitamins DEXA during growth and after puberty Annual dental examinations Developmental and neurocognitive assessment Lung function (spirometry) Sputum cultures Monitor liver enzymes and fat‐soluble vitamins HbA1c/OGTT Nutrition and weight monitoring DEXA every 3–5 years Multidisciplinary Team Haematology Pulmonologist Gastroenterology Orthopaedics Paediatrics Genetics Dental Pulmonology (CF specialist) Paediatrics Endocrine (CF diabetes) Gastroenterology CF specialist nurses Respiratory/physical therapists (physiotherapy) Psychology Pharmacy Dietetics Abbreviations: ABPA, allergic bronchopulmonary aspergillosis; CFTR, cystic fibrosis transmembrane conductance regulator; DEXA, dual‐energy X‐ray absorptiometry; HbA1c, glycated haemoglobin; MDT, multidisciplinary team; MRI, magnetic resonance imaging; NPD, nasal potential difference; OGTT, oral glucose tolerance test; SBDS, Schwachman‐Bodian‐diamond Syndrome. Summary of Shwachman‐Diamond Syndrome (SDS) versus Cystic Fibrosis (CF). Recurrent respiratory infections, often milder than CF Lung disease may progress slowly. Bronchiectasis uncommon early Progressive lung disease (can be severe) Chronic cough, recurrent pneumonia, bronchiectasis, ABPA, chronic infections, for example, with Pseudomonas aeruginosa , Burkholderia cepacia complex, Mycobacterium abscesses Exocrine pancreatic dysfunction in > 90%, typically within first year of diagnosis. In some, function improves spontaneously in childhood Pancreas shows fatty infiltration and acinar cell atrophy Exocrine pancreatic insufficiency is common (90% patients) due to ductal obstruction by thick mucus Pancreatic fibrosis and atrophy are progression. Enzyme replacement is lifelong Bone marrow failure: neutropenia (most common), anaemia, thrombocytopenia are intermittent or persistent Increased risk of myelodysplastic syndrome and leukaemia, most commonly acute myeloid leukaemia No haematological abnormalities Secondary anaemia may occur with chronic disease, infections, iron‐deficiency Metaphyseal dysplasia Delayed epiphyseal ossification Thoracic dystrophy Low‐turnover Osteoporosis Hypertrophic pulmonary osteoarthropathy Osteopenia and osteoporosis – multifactorial, for example, due to chronic corticosteroid use and malabsorption of vitamin D and K Neurocognitive deficits possible. MRI studies show decreased brain volume, especially posterior fossa Developmental delays and learning difficulties may occur No direct neurocognitive abnormalities Psychological problems related to chronic illness (anxiety, depression, treatment burden) Congenital bilateral absence of vas deferens (CBAVD) in males; obstructive azoospermia Females may have subfertility (which generally improves if responsive to CFTR modulators) Endocrine dysfunction, such as hypothyroidism, glucose dysregulation or diabetes Congenital defects Increased risk of oral and dental disease Visual abnormalities (rod‐cone dystrophy) Sensorineural hearing loss CF diabetes Nasal polyps, sinusitis Exact pathogenesis is unclear Affected SDBS protein is involved in ribosome biogenesis and mitotic spindle stabilisation Below 60 mmol/L Elevated (≥ 60 mmol/L) Borderline (30–59 mmol/L), but may be diagnostic if further functional tests (e.g., NPD) are abnormal Usually autosomal recessive Common: variants in the SBDS gene (causes SDS1) Rare: variants in the EFL1 gene (causes SDS2) and DNAJC21 gene (responsible for bone marrow failure syndrome) Rarely autosomal dominant: SRP54 gene (is linked with Shwachman‐Diamond syndrome like (SDSL) and neutropenia) Autosomal recessive > 2000 CFTR variants identified Most common in European and North American populations: common variants include F508del, G551D, G542X Full blood counts every 3–6 months Bone marrow monitoring as indicated Monitor liver enzymes and fat‐soluble vitamins DEXA during growth and after puberty Annual dental examinations Developmental and neurocognitive assessment Lung function (spirometry) Sputum cultures Monitor liver enzymes and fat‐soluble vitamins HbA1c/OGTT Nutrition and weight monitoring DEXA every 3–5 years Haematology Pulmonologist Gastroenterology Orthopaedics Paediatrics Genetics Dental Pulmonology (CF specialist) Paediatrics Endocrine (CF diabetes) Gastroenterology CF specialist nurses Respiratory/physical therapists (physiotherapy) Psychology Pharmacy Dietetics Abbreviations: ABPA, allergic bronchopulmonary aspergillosis; CFTR, cystic fibrosis transmembrane conductance regulator; DEXA, dual‐energy X‐ray absorptiometry; HbA1c, glycated haemoglobin; MDT, multidisciplinary team; MRI, magnetic resonance imaging; NPD, nasal potential difference; OGTT, oral glucose tolerance test; SBDS, Schwachman‐Bodian‐diamond Syndrome. Diagnosis relies on clinical suspicion supported by genetic analysis [2]. In the Boston Children's SDS Registry (n = 419), SBDS mutations were detected in 62%; 4% had rarer implicated genes, 34% had no identifiable genetic cause. In our case, further supporting its likely pathogenic nature, a novel missense variant at a previously reported pathogenic codon was identified (c.284T>A, p.Val95Glu) [3], further supporting its likely pathogenic nature. Management overlaps, but key differences exist. Both conditions require respiratory care, pancreatic enzyme replacement and attention to bone health and fat‐soluble vitamins. SDS additionally requires haematologic monitoring and surveillance for clonal evolution/malignancy [7]. This case highlights two practical messages: Think beyond CF. Consider SDS in CF‐like presentations with atypical features and equivocal or negative CF diagnostic tests. Think beyond CF. Consider SDS in CF‐like presentations with atypical features and equivocal or negative CF diagnostic tests. Milder phenotypes of SDS survive into adulthood. Respiratory physicians should recognise SDS as an important differential for recurrent respiratory infections and pancreatic insufficiency where there is no secure CF diagnosis. Milder phenotypes of SDS survive into adulthood. Respiratory physicians should recognise SDS as an important differential for recurrent respiratory infections and pancreatic insufficiency where there is no secure CF diagnosis. Author Contributions Acquisition of patient history: F.Y., L.W. Drafting the manuscript: F.Y. Critical revision of the manuscript: F.Y., L.W., I.F., N.J.S. Guarantor: N.J.S. Consent The authors declare that written informed consent was obtained for the publication of this manuscript and attest that the form used to obtain consent from the patient complies with the journal requirements as outlined in the author guidelines. Conflicts of Interest F.Y. has received honoraria for attending meetings and speaker fees from AstraZeneca and GlaxoSmithKline, and is a member of the BTS asthma specialist advisory group. L.W. has no conflicts of interest; I.F. has received honoraria for educational symposia by Vertex. N.J.S. has received honoraria for advisory boards from Vertex, Boehringer Ingelheim, Chiesi, Gilead, and Menarini. He has also received honoraria for educational activities from Vertex, Chiesi, Gilead, Medison, Teva, and Zambon. Yang F., Weitnauer L., Felton I., and Simmonds N. J., “Beyond Cystic Fibrosis: Recognising Shwachman‐Diamond Syndrome in the Respiratory Clinic,” Respirology Case Reports 13, no. 12 (2025): e70440, 10.1002/rcr2.70440. Associate Editor: Takumi Takizawa Data Availability Statement The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. References Associated Data Data Availability Statement The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.